IT201900023454A1 - Composizione nutraceutica ricostituente del metabolismo energetico - Google Patents
Composizione nutraceutica ricostituente del metabolismo energeticoInfo
- Publication number
- IT201900023454A1 IT201900023454A1 IT102019000023454A IT201900023454A IT201900023454A1 IT 201900023454 A1 IT201900023454 A1 IT 201900023454A1 IT 102019000023454 A IT102019000023454 A IT 102019000023454A IT 201900023454 A IT201900023454 A IT 201900023454A IT 201900023454 A1 IT201900023454 A1 IT 201900023454A1
- Authority
- IT
- Italy
- Prior art keywords
- restorative
- energy metabolism
- nutraceutical composition
- nutraceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000023454A IT201900023454A1 (it) | 2019-12-10 | 2019-12-10 | Composizione nutraceutica ricostituente del metabolismo energetico |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000023454A IT201900023454A1 (it) | 2019-12-10 | 2019-12-10 | Composizione nutraceutica ricostituente del metabolismo energetico |
Publications (1)
Publication Number | Publication Date |
---|---|
IT201900023454A1 true IT201900023454A1 (it) | 2021-06-10 |
Family
ID=70154958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102019000023454A IT201900023454A1 (it) | 2019-12-10 | 2019-12-10 | Composizione nutraceutica ricostituente del metabolismo energetico |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT201900023454A1 (it) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005023008A (ja) * | 2003-07-01 | 2005-01-27 | Sankyo Co Ltd | ビタミンb群を含有する内服液剤組成物 |
CN101617785A (zh) * | 2009-08-17 | 2010-01-06 | 刘富海 | 一种蜂蜜王浆复配食品及其制作工艺 |
US20120294983A1 (en) * | 2006-04-05 | 2012-11-22 | Wyeth Llc | Nutritional Formulation |
CN109170736A (zh) * | 2018-10-24 | 2019-01-11 | 北京华润高科天然药物有限公司 | 一种蜂王浆的预处理方法及蜂王精口服液的制备方法 |
US10398741B2 (en) * | 2015-01-22 | 2019-09-03 | Yamada Bee Company, Inc. | Composition |
-
2019
- 2019-12-10 IT IT102019000023454A patent/IT201900023454A1/it unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005023008A (ja) * | 2003-07-01 | 2005-01-27 | Sankyo Co Ltd | ビタミンb群を含有する内服液剤組成物 |
US20120294983A1 (en) * | 2006-04-05 | 2012-11-22 | Wyeth Llc | Nutritional Formulation |
CN101617785A (zh) * | 2009-08-17 | 2010-01-06 | 刘富海 | 一种蜂蜜王浆复配食品及其制作工艺 |
US10398741B2 (en) * | 2015-01-22 | 2019-09-03 | Yamada Bee Company, Inc. | Composition |
CN109170736A (zh) * | 2018-10-24 | 2019-01-11 | 北京华润高科天然药物有限公司 | 一种蜂王浆的预处理方法及蜂王精口服液的制备方法 |
Non-Patent Citations (5)
Title |
---|
DATABASE GNPD [online] MINTEL; 15 May 2019 (2019-05-15), ANONYMOUS: "Orange-Honey Flavoured Royal Jelly", XP055724180, retrieved from www.gnpd.com Database accession no. 6547731 * |
DATABASE WPI Week 200513, Derwent World Patents Index; AN 2005-116001 * |
DATABASE WPI Week 201009, Derwent World Patents Index; AN 2010-A74352 * |
DATABASE WPI Week 201928, Derwent World Patents Index; AN 2019-08456Q * |
KUNUGI ET AL: "Royal Jelly and Its Components Promote Healthy Aging and Longevity: From Animal Models to Humans", INT. J. MOL. SCI., vol. 20, no. 19, 20 October 2019 (2019-10-20), pages 4662, XP055723874, ISSN: 1661-6596, DOI: 10.3390/ijms20194662 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283725A (en) | Preparations and methods for increasing the efficiency of heart metabolism | |
CO2018003678A2 (es) | Composiciones y métodos para inhibir la expresión génica de lpa | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
DK3355990T3 (da) | Semifluorinerede forbindelser og disses sammensætninger | |
CL2016002764A1 (es) | Composiciones y métodos para modular la expresión del factor b del complemento | |
PL3307289T3 (pl) | Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt) | |
CR20140200A (es) | Formas solidas de 3-(5-amino-2-metil-4-oxo-ah-quinazolin-3-il)-piperidin-2,6-diona, y sus composiciones farmaceuticas y sus usos | |
CL2015000530A1 (es) | Compuestos derivados ciclicos eter pirazol-4-il-heterociclil-carboxamida, como inhibidores de la quinasa pim; composicion farmaceutica que los comprende; y su uso para el tratamiento de cancer, trastornos inmunologicos, enfermedades cardiovasculares, infeccion virica, inflamacion, trastornos del metabolismo/funcion endocrina y trastornos neurologicos. | |
MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
CL2017002334A1 (es) | Combinaciones y formulaciones de dosis fijas que comprenden etc-1002 y una o más estatinas y métodos para tratar o reducir el riesgo de enfermedad cardiovascular | |
IT201600121601A1 (it) | Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo | |
DK3768284T3 (da) | Sammensætninger af enterococcus flagellin til anvendelse i terapi | |
MA49981A (fr) | Procédés et compositions de préparation de cellules génétiquement modifiées | |
CR20150653A (es) | Compuestos nuevos para el tratamiento del cáncer | |
ITUA20162575A1 (it) | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa | |
CR20170090A (es) | Derivados de terahidroquinolina como inhibidores del bromodominio | |
ITUA20163269A1 (it) | Composizione ad assorbimento orobuccale per la neuro-protezione | |
ZA201801015B (en) | Oral care compositions and methods of using the compositions | |
DK3129057T3 (da) | Glykolipider og farmaceutiske sammensætninger deraf til anvendelse i terapi | |
IT201600121617A1 (it) | Composizione per il trattamento del reflusso gastroesofageo | |
IT201900019391A1 (it) | Composizione per la riduzione del rischio cardiovascolare | |
IT201700108526A1 (it) | Composizioni orali per il trattamento del refluso gastroesofageo. | |
BR112018008651A2 (pt) | formulação de combinação de dose fixa de eflornitina e sulindaco | |
IT201900023454A1 (it) | Composizione nutraceutica ricostituente del metabolismo energetico | |
MA51009A (fr) | Composition de soins buccaux |